Hong Kong introduces a new list of key enterprises, including three of the world's top ten pharmaceutical companies, as well as Little Red Book.

On October 9th, the Hong Kong Mainland Offices of Key Enterprises held a "Key Enterprise Partners Signing Ceremony" and announced the list of the 5th batch of key enterprises, covering 18 companies from both domestic and overseas, including 3 of the top 10 global pharmaceutical companies: British GlaxoSmithKline plc Sponsored ADR (GSK.US), Swiss Roche (RHHBY.US), and German Merck, as well as mainland social platform "Xiaohongshu" and the US creative technology company Vobile Group (03738). During his speech, the Financial Secretary of Hong Kong, Paul Chan Mo-po, stated that with the arrival of the new batch of enterprises to develop their businesses in Hong Kong, the total number of key enterprises that have been facilitated to settle in Hong Kong has exceeded 100, bringing in over HK$60 billion of investment and creating approximately 22,000 jobs. Paul Chan Mo-po mentioned that the new batch of key enterprises come from different cutting-edge industries, including leading global pharmaceutical companies, artificial intelligence, and new media, marking an important milestone. By introducing revolutionary ideas, world-class expertise, a global perspective, and innovative spirit, they will further enrich Hong Kong's rapidly developing innovation and technology ecosystem. He also noted that for the first time, the new batch of enterprises includes creative technology companies, recognizing the rapid growth of the global digital entertainment market. Hong Kong's unique advantage as an internationally connected city with an open and diverse atmosphere makes it an ideal platform for these companies to expand and thrive in Asia and even globally.